Matches in Wikidata for { <http://www.wikidata.org/entity/Q87837605> ?p ?o ?g. }
- Q87837605 description "2017 թվականի ապրիլի 11-ին հրատարակված գիտական հոդված" @default.
- Q87837605 description "article scientifique publié en 2017" @default.
- Q87837605 description "artículu científicu espublizáu n'abril de 2017" @default.
- Q87837605 description "scientific article published on 11 April 2017" @default.
- Q87837605 description "wetenschappelijk artikel" @default.
- Q87837605 description "наукова стаття, опублікована у квітні 2017" @default.
- Q87837605 name "Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial" @default.
- Q87837605 name "Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial" @default.
- Q87837605 type Item @default.
- Q87837605 label "Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial" @default.
- Q87837605 label "Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial" @default.
- Q87837605 prefLabel "Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial" @default.
- Q87837605 prefLabel "Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial" @default.
- Q87837605 P1433 Q87837605-5F1DAA05-0F72-4252-BF83-4F7C2D1D58B5 @default.
- Q87837605 P1476 Q87837605-C23AEAE5-D080-46BD-97DC-345BC5092B66 @default.
- Q87837605 P2093 Q87837605-022B813C-C2D6-463A-A1B2-9313B67AEB0B @default.
- Q87837605 P2093 Q87837605-14BC3071-5DB8-4EA8-B20A-5C846A81691E @default.
- Q87837605 P2093 Q87837605-1FF7161E-EFA7-4BD1-9E50-1D77DD247672 @default.
- Q87837605 P2093 Q87837605-3B134C0A-0B4F-4678-ACE4-DD80C1D22EF0 @default.
- Q87837605 P2093 Q87837605-81D70BE2-9E08-467E-BC33-52E20AA9CB04 @default.
- Q87837605 P2093 Q87837605-8B53A4FF-359B-4B8A-816A-0B76CB279F6F @default.
- Q87837605 P2093 Q87837605-8EB3FFEE-2183-4BC4-AD58-C41B501CE8F0 @default.
- Q87837605 P2093 Q87837605-98EE4FBC-E988-46DF-BF3E-70F055DF2FB5 @default.
- Q87837605 P2093 Q87837605-9EF245D2-B031-4C1C-9EAC-3D346FE807CB @default.
- Q87837605 P2093 Q87837605-9F0412D6-B917-4A7F-8C89-DCC4FA9DD1BA @default.
- Q87837605 P2093 Q87837605-A87FD4B2-CD4E-4721-AFB0-B3ACF251D36B @default.
- Q87837605 P2093 Q87837605-ABB24E3C-924D-44D4-8723-09CF61DC89EC @default.
- Q87837605 P2093 Q87837605-D1214FAD-BAF2-43F8-AC6F-E47698735AEE @default.
- Q87837605 P2093 Q87837605-E4828DC2-ABBC-4FC7-8AA4-5571B1958B72 @default.
- Q87837605 P2093 Q87837605-E71ECA16-A5B5-48DC-98DD-12504EE7529E @default.
- Q87837605 P2860 Q87837605-00560B9F-FC9E-4410-9A0A-5DB8E27A28B7 @default.
- Q87837605 P2860 Q87837605-04AA42C4-CCD5-42C6-A8EE-FC178E2008E8 @default.
- Q87837605 P2860 Q87837605-050646D3-2470-4A49-9262-EE5FDF588611 @default.
- Q87837605 P2860 Q87837605-141B38B4-E5CF-4A4A-A76C-69B75B187B85 @default.
- Q87837605 P2860 Q87837605-174FB205-2C2B-4E2C-947A-F2397D0E33DA @default.
- Q87837605 P2860 Q87837605-1804D472-E9D2-4FD8-9C66-6D47C7B60C99 @default.
- Q87837605 P2860 Q87837605-2CA3C973-9231-4C09-B98B-448C7F267EF4 @default.
- Q87837605 P2860 Q87837605-47F3A59B-24AF-4084-B925-A51BD1262467 @default.
- Q87837605 P2860 Q87837605-6210B99F-8DA3-45A5-9764-41BAAC4C2CE0 @default.
- Q87837605 P2860 Q87837605-621789CB-ADC6-4C76-9DC9-23C4679025A3 @default.
- Q87837605 P2860 Q87837605-7852FABC-6E36-46DD-A177-A81FA84C4EDA @default.
- Q87837605 P2860 Q87837605-78CFA3BE-84D6-4E90-8613-8A31AD637B14 @default.
- Q87837605 P2860 Q87837605-871CB99F-4F1F-484E-8D5C-712C09715602 @default.
- Q87837605 P2860 Q87837605-8DA04DA9-A88E-41C9-91A6-03D29C861654 @default.
- Q87837605 P2860 Q87837605-8F64C007-9B7B-4174-8E4B-1795914C8FF0 @default.
- Q87837605 P2860 Q87837605-96E8D53F-0FAB-4D9B-B603-6373885E8B65 @default.
- Q87837605 P2860 Q87837605-A1BB60E3-75B7-4F66-A733-A2AFD4E6351E @default.
- Q87837605 P2860 Q87837605-A524F8FB-1A3D-4F8D-A284-5D963FAF577B @default.
- Q87837605 P2860 Q87837605-B122F5D9-D6B9-4EC7-A8AC-A66B55CBA2AF @default.
- Q87837605 P2860 Q87837605-C6F08F87-7540-44C4-8C4F-86C64BC1A19D @default.
- Q87837605 P2860 Q87837605-CAA050F7-CF40-4FC1-BE84-97E4A0B474C7 @default.
- Q87837605 P2860 Q87837605-E5A51B02-CF43-439C-B63C-F2E19F69065C @default.
- Q87837605 P2860 Q87837605-E8E394A6-D9EA-4775-A8A5-506438A3C785 @default.
- Q87837605 P2860 Q87837605-ECA59F08-9B60-4342-923A-2D56E22CBEA5 @default.
- Q87837605 P2860 Q87837605-ED7B037E-97EC-4AA4-A824-BB726CB5BDE6 @default.
- Q87837605 P2860 Q87837605-F191B586-4389-4E45-B161-1B4FD083EFDD @default.
- Q87837605 P2860 Q87837605-F69D2030-E655-48AC-B42E-5526721B459E @default.
- Q87837605 P2860 Q87837605-F8B84EC5-AD1C-4E50-A60C-D3B31E83014C @default.
- Q87837605 P304 Q87837605-4EF22379-D0D1-4DA0-8375-9D5BA5231E17 @default.
- Q87837605 P31 Q87837605-F949AC8E-B592-46DA-B146-D3E458ECDBE0 @default.
- Q87837605 P356 Q87837605-C40040ED-4483-4651-8A04-57928AB2DFD2 @default.
- Q87837605 P407 Q87837605-6E14BE22-3752-46CD-8D6E-988703D449B8 @default.
- Q87837605 P433 Q87837605-D8D11A56-D882-412A-9E3D-AA877F8FC186 @default.
- Q87837605 P478 Q87837605-5C4040F4-EC25-44B3-8F66-FA03C7BDC24F @default.
- Q87837605 P50 Q87837605-8C19F563-15A0-46BC-A80A-ACD09EE6BC14 @default.
- Q87837605 P577 Q87837605-81322533-86F4-4CF2-B0F5-E1C1829AE7EE @default.
- Q87837605 P698 Q87837605-F3219294-170D-44CA-B573-BF7905237BC1 @default.
- Q87837605 P921 Q87837605-92094138-66AF-4B55-B68E-2121DD78B355 @default.
- Q87837605 P356 S0140-6736(17)30981-9 @default.
- Q87837605 P698 28410791 @default.
- Q87837605 P1433 Q939416 @default.
- Q87837605 P1476 "Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial" @default.
- Q87837605 P2093 "Angeline Lo" @default.
- Q87837605 P2093 "Bing Y Suen" @default.
- Q87837605 P2093 "Francis K L Chan" @default.
- Q87837605 P2093 "Grace L H Wong" @default.
- Q87837605 P2093 "Heyson Chan" @default.
- Q87837605 P2093 "Jessica Y L Ching" @default.
- Q87837605 P2093 "Justin C Y Wu" @default.
- Q87837605 P2093 "Ka Man Kee" @default.
- Q87837605 P2093 "Kelvin Lam" @default.
- Q87837605 P2093 "Kim W L Au" @default.
- Q87837605 P2093 "Moe H Kyaw" @default.
- Q87837605 P2093 "Pui Kuan Cheong" @default.
- Q87837605 P2093 "Siew C Ng" @default.
- Q87837605 P2093 "Vincent W S Wong" @default.
- Q87837605 P2093 "Yee Kit Tse" @default.
- Q87837605 P2860 Q24546221 @default.
- Q87837605 P2860 Q24619410 @default.
- Q87837605 P2860 Q24646764 @default.
- Q87837605 P2860 Q28164178 @default.
- Q87837605 P2860 Q28167963 @default.
- Q87837605 P2860 Q28186337 @default.
- Q87837605 P2860 Q28195282 @default.
- Q87837605 P2860 Q28200375 @default.
- Q87837605 P2860 Q28211411 @default.
- Q87837605 P2860 Q28217835 @default.
- Q87837605 P2860 Q28222704 @default.
- Q87837605 P2860 Q29619529 @default.
- Q87837605 P2860 Q29620671 @default.